iGEM Competition

iGEM Competition
Name	iGEM Competition
Caption	iGEM trophy
Established	2003
Organizer	International Genetically Engineered Machine Foundation
Frequency	Annual
Participants	Undergraduate, high school, and community teams
Location	Global

iGEM Competition

The International Genetically Engineered Machine (iGEM) competition is an annual global synthetic biology contest that brings together student teams from universities, Massachusetts Institute of Technology, Harvard University, Stanford University, University of Cambridge, University of Oxford, California Institute of Technology, University of Tokyo, ETH Zurich, University of California, Berkeley, Imperial College London, University of Toronto, Peking University, Tsinghua University, National University of Singapore, University of Melbourne, University of Sydney, University of Washington, Columbia University, Princeton University, Yale University, Duke University, University of Pennsylvania, Cornell University, University of Chicago, University College London, University of Edinburgh, University of Hong Kong, McGill University, University of British Columbia, Seoul National University, KAIST, Indian Institute of Technology Bombay, Indian Institute of Science, Technion – Israel Institute of Technology, University of São Paulo, Universidad Nacional Autónoma de México, University of Cape Town, Aarhus University, Lomonosov Moscow State University, Sorbonne Université, Heidelberg University, Ludwig Maximilian University of Munich, University of Amsterdam, Trinity College Dublin, Monash University, Ecole Polytechnique Fédérale de Lausanne, University of Groningen, University of Bologna, University of Barcelona, Seville University, University of Helsinki, University of Oslo, Uppsala University, Karolinska Institutet, University of Geneva, Ruprecht-Karls-Universität Heidelberg and others to design genetic systems, biological parts, and applications.

Overview

iGEM foregrounds engineering approaches to synthetic biology by providing a platform where teams design, build, and test biological systems using standardized DNA parts and present results at an annual Giant Jamboree in Boston, Massachusetts, often hosted near Massachusetts Institute of Technology and attended by representatives from organizations such as the World Health Organization, European Union, National Institutes of Health, Wellcome Trust, Howard Hughes Medical Institute, Bill & Melinda Gates Foundation, Biotechnology Innovation Organization, Royal Society, Academy of Medical Sciences, United Nations Educational, Scientific and Cultural Organization, European Molecular Biology Laboratory, European Research Council, Japan Society for the Promotion of Science, National Science Foundation, Defense Advanced Research Projects Agency, Sanger Institute, Broad Institute, Cold Spring Harbor Laboratory, Institut Pasteur, Riken, Max Planck Society, CNRS, CSIRO, Fraunhofer Society, Novartis, Pfizer, Roche, Sanofi, AstraZeneca, GlaxoSmithKline, Merck & Co..

History

Origins trace to the 2003 MIT International Genetically Engineered Machine student project, evolving through early collaborations with College Open Learning Exchange-era synthetic biology groups and workshops at Cold Spring Harbor Laboratory and Whitehead Institute. The competition’s growth involved partnerships with institutions like MIT Media Lab, Harvard Medical School, Broad Institute, European Molecular Biology Organization, and funders such as Wellcome Trust and National Institutes of Health. Milestones include expansion to high school teams inspired by programs at Stuyvesant High School and Phillips Exeter Academy, regional jamborees across Asia, Europe, Africa, and the Americas, and awards ceremonies that have featured judges from Nobel Prize laureates, leaders from Royal Society, Academy of Medical Sciences, and executives from Biotechnology Innovation Organization and pharmaceutical firms including Novartis and Pfizer.

Competition Structure and Categories

Teams register with the iGEM Foundation and follow a seasonal cycle culminating in the Giant Jamboree where awards mirror categories similar to those used by organizations like IEEE and ACM. Categories include performance-based awards for laboratory research, software, and hardware that reflect practices seen at International Genetically Engineered Machine-style events and comparable competitions such as the Google Science Fair, Intel International Science and Engineering Fair, FIRST Robotics Competition, Formula Student, and DARPA Grand Challenge. Judging panels often include members from Nature Biotechnology, Science Translational Medicine, Cell Press, Journal of Biological Engineering, PLOS ONE, and representatives from funders like the Wellcome Trust, European Research Council, National Science Foundation, Japan Society for the Promotion of Science, and industrial partners including Roche, AstraZeneca, Sanofi, GlaxoSmithKline, Merck & Co., and Bayer.

Projects and Notable Achievements

Teams have produced modular biological parts registered in the Registry of Standard Biological Parts, contributed software tools resembling efforts from Addgene, Benchling, SnapGene, BLAST-integrated pipelines, and demonstrated applications in diagnostics, bioremediation, therapeutics, agriculture, and biosensing. Influential projects drew attention alongside work at Broad Institute, CRISPR Therapeutics, Editas Medicine, Intellia Therapeutics, Caribou Biosciences, Synthego, Genentech, Ginkgo Bioworks, Zymergen, and startups incubated in Y Combinator, IndieBio, Biolabs, Cambridge Innovation Center. Notable achievements include advances cited in venues such as Nature, Science, Cell, Nature Biotechnology, PNAS, eLife, and awards presented at gatherings attended by members of Royal Society, recipients of the Nobel Prize in Chemistry and Nobel Prize in Physiology or Medicine.

Education, Outreach, and Ethics

iGEM emphasizes training in laboratory techniques used at institutions like Cold Spring Harbor Laboratory, Broad Institute, Wellcome Sanger Institute, EMBL, Riken, and Max Planck Institutes, and integrates policy, biosafety, and biosecurity curricula paralleling programs at Johns Hopkins Bloomberg School of Public Health, Harvard T.H. Chan School of Public Health, London School of Hygiene & Tropical Medicine, and ETH Zurich. Outreach initiatives have engaged partners including UNESCO, WHO, Bill & Melinda Gates Foundation, Gavi, the Vaccine Alliance, American Association for the Advancement of Science, Royal Institution, Science Museum London, Smithsonian Institution, National Academy of Sciences, European Commission, U.S. Department of Energy, and National Institutes of Health to address Responsible Research and Innovation frameworks and the Nagoya Protocol.

Impact and Criticism

Advocates cite iGEM’s role in workforce development feeding academic and industrial pathways at MIT, Harvard, Stanford, Broad Institute, Ginkgo Bioworks, Genentech, Novartis, Roche, and startups from Y Combinator and IndieBio. Critics raise concerns echoed in debates at European Parliament, United Nations, World Health Organization, Royal Society, National Academy of Sciences, and in publications in Nature and Science about biosafety, dual-use research, and commercialization pressures, prompting policy responses from bodies such as European Commission, National Institutes of Health, Office of Science and Technology Policy, and institutional review boards at universities like MIT, Harvard, Stanford, and University of Cambridge.

Category:Synthetic biology competitions